v3.26.1
Composition of Certain Condensed Consolidated Financial Statement Line Items (Tables)
3 Months Ended
Mar. 31, 2026
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of Property and Equipment, Net
Property and equipment consisted of the following:
(in thousands)March 31,
2026
December 31,
2025
Laboratory equipment$6,593 $6,531 
Leasehold improvements118 118 
Computer hardware542 542 
Furniture, fixtures and office equipment322 322 
Prototype equipment2,323 2,258 
Construction in progress2,197 1,807 
12,095 11,578 
Less: Accumulated depreciation(8,460)(8,121)
Total$3,635 $3,457 
Schedule of Accrued Expenses
Accrued expenses and other liabilities consisted of the following:
(in thousands)March 31,
2026
December 31,
2025
Employee compensation$2,414 $2,514 
Accrued research and development
337 221 
Accrued professional and consulting fees
325 259 
Other229 183 
Total$3,305 $3,177 
Schedule of Other Liabilities
Accrued expenses and other liabilities consisted of the following:
(in thousands)March 31,
2026
December 31,
2025
Employee compensation$2,414 $2,514 
Accrued research and development
337 221 
Accrued professional and consulting fees
325 259 
Other229 183 
Total$3,305 $3,177 
Schedule of Cash and Cash Equivalents
Cash, cash equivalents and restricted cash consisted of the following:
(in thousands)March 31,
2026
December 31,
2025
Cash and cash equivalents$14,626 $12,388 
Restricted cash included in other long-term assets (Note 8)1,002 1,002 
Total$15,628 $13,390 
Schedule of Restricted Cash
Cash, cash equivalents and restricted cash consisted of the following:
(in thousands)March 31,
2026
December 31,
2025
Cash and cash equivalents$14,626 $12,388 
Restricted cash included in other long-term assets (Note 8)1,002 1,002 
Total$15,628 $13,390